Novartis Company Profile
✉ Email this page to a colleague
Biologic Drugs for Novartis
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Patent No. | Estimated Patent Expiration | Source |
---|---|---|---|---|---|---|---|
Novartis Pharmaceuticals Corporation | SIMULECT | basiliximab | For Injection | 103764 | 10,064,938 | 2036-03-11 | Patent claims search |
Novartis Pharmaceuticals Corporation | SIMULECT | basiliximab | For Injection | 103764 | 10,086,046 | 2028-05-08 | Patent claims search |
Novartis Pharmaceuticals Corporation | SIMULECT | basiliximab | For Injection | 103764 | 10,111,968 | 2032-02-15 | Patent claims search |
Novartis Pharmaceuticals Corporation | SIMULECT | basiliximab | For Injection | 103764 | 10,159,710 | 2031-12-22 | Patent claims search |
Novartis Pharmaceuticals Corporation | SIMULECT | basiliximab | For Injection | 103764 | 10,166,244 | 2027-01-12 | Patent claims search |
Novartis Pharmaceuticals Corporation | SIMULECT | basiliximab | For Injection | 103764 | 10,251,871 | 2035-02-05 | Patent claims search |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Patent No. | >Estimated Patent Expiration | >Source |
Similar Applicant Names
This search can help find similar names.